Go to the Table Of Contents

Results from the 2007
National Survey on Drug Use and Health:
National Findings

 

 

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration (SAMHSA)
Office of Applied Studies (OAS)

Acknowledgments

This report was prepared by the Division of Population Surveys, Office of Applied Studies, SAMHSA, and by RTI International, a trade name of Research Triangle Institute, Research Triangle Park, North Carolina. Work by RTI was performed under Contract No. 283-2004-00022. Contributors and reviewers at RTI listed alphabetically include Jeremy Aldworth, Kimberly Ault, Ellen Bishop, Lisa Carpenter, Patrick Chen, James R. Chromy, Elizabeth Copello, David B. Cunningham, Lanting Dai, Teresa R. Davis, Ralph E. Folsom, Jr., Misty Foster, Peter Frechtel, G. G. Frick, Julia Gable, Jody M. Greene, Wafa Handley, David C. Heller, Erica Hirsch, Ilona Johnson, Lauren Klein, Larry A. Kroutil, Bing Liu, Mary Ellen Marsden, Katherine B. Morton, Breda Munoz, Scott Novak, Lisa E. Packer, Lanny Piper, Jeremy Porter, Heather Ringeisen, Tania Robbins, Harley Rohloff, Kathryn Spagnola, Thomas G. Virag (Project Director), Michael Vorburger, and Jiantong Wang. Contributors at SAMHSA listed alphabetically, with chapter authorship noted, include Peggy Barker, Jonaki Bose, James Colliver (Chapters 2 and 4), Lisa Colpe (Chapter 8), Joseph Gfroerer (Chapters 1 and 9), Beth Han (Chapters 6 and 7), Arthur Hughes (Project Officer), Joel Kennet (Chapter 3), Pradip Muhuri (Chapter 5), and Dicy Painter. Also at RTI, report and web production staff listed alphabetically include Teresa G. Bass, Wendy Broome, Cassandra M. Carter, Joyce Clay-Brooks, Diane G. Eckard, Shari B. Lambert, Danny Occoquan, Brenda K. Porter, Pamela Couch Prevatt, and Richard S. Straw. Final report production was provided by Beatrice Rouse, Coleen Sanderson, and Jane Feldmann at SAMHSA.

Public Domain Notice

All material appearing in this report is in the public domain and may be reproduced or copied without permission from the Substance Abuse and Mental Health Services Administration. However, this publication may not be reproduced or distributed for a fee without specific, written authorization of the Office of Communications, SAMHSA, U.S. Department of Health and Human Services. Citation of the source is appreciated. Suggested citation:

Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2008). Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD.

Electronic Access to Publication

This publication may be downloaded from http://oas.samhsa.gov.
Hard copies may be obtained from http://oas.samhsa.gov/copies.cfm.

Or please call SAMHSA's Health Information Network at:
1-877-SAMHSA-7 (1-877-726-4727)
(English and Español).

Originating Office

SAMHSA, Office of Applied Studies
1 Choke Cherry Road, Room 7-1044
Rockville, MD 20857

September 2008

Skip To Content
Click for DHHS Home Page
Click for the SAMHSA Home Page
Click for the OAS Drug Abuse Statistics Home Page
Click for What's New
Click for Recent Reports and HighlightsClick for Information by Topic Click for OAS Data Systems and more Pubs Click for Data on Specific Drugs of Use Click for Short Reports and Facts Click for Frequently Asked Questions Click for Publications Click to send OAS Comments, Questions and Requests Click for OAS Home Page Click for Substance Abuse and Mental Health Services Administration Home Page Click to Search Our Site

2007 National Survey on Drug Use & Health:  National Results

Table of Contents

Citation:

Substance Abuse and Mental Health Services Administration, Office of Applied Studies (2008). Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD.

Skip to main content

Cover
Acknowledgements

List of Figures
List of Tables

Highlights

1. Introduction
1.1. Summary of NSDUH
1.2. Trend Measurement
1.3. Change in Estimates for Psychotherapeutic Drugs and Stimulants
1.4. Format of Report and Explanation of Tables
1.5. Other NSDUH Reports and Data

2. Illicit Drug Use
Age
Youths Aged 12 to 17
Young Adults Aged 18 to 25
Adults Aged 26 or Older
Gender
Pregnant Women
Race/Ethnicity
Education
College Students
Employment
Geographic Area
Criminal Justice Populations
Frequency of Use
Association with Cigarette and Alcohol Use
Driving Under the Influence of Illicit Drugs
Source of Prescription Drugs

3. Alcohol Use
3.1. Alcohol Use among Persons Aged 12 or Older
Age
Gender
Pregnant Women
Race/Ethnicity
Education
College Students
Employment
Geographic Area
Association with Illicit Drug and Tobacco Use
Driving Under the Influence of Alcohol
3.2. Underage Alcohol Use

4. Tobacco Use
Age
Gender
Pregnant Women
Race/Ethnicity
Education
College Students
Employment
Geographic Area
Association with Illicit Drug and Alcohol Use
Frequency of Cigarette Use

5. Initiation of Substance Use
Initiation of Illicit Drug Use
Comparison, by Drug
Marijuana
Cocaine
Heroin
Hallucinogens
Inhalants
Psychotherapeutics
Alcohol
Tobacco

6. Youth Prevention-Related Measures
Perceptions of Risk
Perceived Availability
Perceived Parental Disapproval of Substance Use
Feelings about Peer Substance Use
Fighting and Delinquent Behavior
Religious Beliefs and Participation in Activities
Exposure to Substance Use Prevention Messages and Programs
Parental Involvement

7. Substance Dependence, Abuse, and Treatment
7.1. Substance Dependence or Abuse
Age at First Use
Age
Gender
Race/Ethnicity
Education/Employment
Criminal Justice Populations
Geographic Area
7.2. Past Year Treatment for a Substance Use Problem
7.3. Need for and Receipt of Specialty Treatment
Illicit Drug or Alcohol Use Treatment and Treatment Need
Illicit Drug Use Treatment and Treatment Need
Alcohol Use Treatment and Treatment Need

8. Mental Health
8.1. Adults Aged 18 or Older
Prevalence of Serious Psychological Distress among Adults
Mental Health Service Use among Adults with Serious Psychological Distress
Serious Psychological Distress and Substance Use and Dependence or Abuse among Adults
Mental Health Care among Adults with Co-Occurring Serious Psychological Distress and Substance Use Disorders
Prevalence of Major Depressive Episode among Adults
Major Depressive Episode and Substance Use and Dependence or Abuse among Adults
Treatment for Major Depressive Episode among Adults
Mental Health Service Use and Unmet Need for Mental Health Care among Adults
8.2. Youths Aged 12 to 17
Prevalence of Major Depressive Episode among Youths
Major Depressive Episode and Substance Use among Youths
Treatment for Major Depressive Episode among Youths
Mental Health Service Use among Youths

9. Discussion of Trends in Substance Use among Youths and Young Adults

Appendix

A. Description of the Survey
B. Statistical Methods and Measurement
C. Key Definitions, 2007
D. Other Sources of Data
E. References
F. Sample Size and Population Tables
G. Selected Prevalence Tables

List of Figures

2.1 Past Month Illicit Drug Use among Persons Aged 12 or Older: 2007

2.2 Past Month Use of Selected Illicit Drugs among Persons Aged 12 or Older: 2002-2007

2.3 Past Month Nonmedical Use of Types of Psychotherapeutic Drugs among Persons Aged 12 or Older: 2002-2007

2.4 Past Month Illicit Drug Use among Persons Aged 12 or Older, by Age: 2007

2.5 Past Month Use of Selected Illicit Drugs among Youths Aged 12 to 17: 2002-2007

2.6 Past Month Use of Selected Illicit Drugs among Young Adults Aged 18 to 25: 2002-2007

2.7 Past Month Illicit Drug Use among Adults Aged 50 to 59: 2002-2007

2.8 Past Month Marijuana Use among Youths Aged 12 to 17, by Gender: 2002-2007

2.9 Past Month Illicit Drug Use among Persons Aged 12 or Older, by Race/Ethnicity: 2007

2.10 Past Month Illicit Drug Use among Persons Aged 18 or Older, by Employment Status: 2007

2.11 Past Month Illicit Drug Use among Persons Aged 12 or Older, by County Type: 2007

3.1 Current, Binge, and Heavy Alcohol Use among Persons Aged 12 or Older, by Age: 2007

3.2 Current, Binge, and Heavy Alcohol Use among Persons Aged 12 or Older, by Race/Ethnicity: 2007

3.3 Heavy Alcohol Use among Adults Aged 18 to 22, by College Enrollment: 2002-2007

3.4 Driving Under the Influence of Alcohol in the Past Year among Persons Aged 12 or Older: 2002-2007

3.5 Driving Under the Influence of Alcohol in the Past Year among Persons Aged 16 or Older, by Age: 2007

3.6 Current Alcohol Use among Persons Aged 12 to 20, by Age: 2002-2007

3.7 Current, Binge, and Heavy Alcohol Use among Persons Aged 12 to 20, by Gender: 2007

4.1 Past Month Tobacco Use among Persons Aged 12 or Older: 2002-2007

4.2 Past Month Tobacco Use among Youths Aged 12 to 17: 2002-2007

4.3 Past Month Cigarette Use among Persons Aged 12 or Older, by Age: 2007

4.4 Past Month Cigarette Use among Youths Aged 12 to 17, by Gender: 2002-2007

4.5 Past Month Cigarette Use among Women Aged 15 to 44, by Pregnancy Status: Combined Years 2002-2003 to 2006-2007

4.6 Past Month Tobacco Use among Adults Aged 18 or Older, by Education: 2007

5.1 Specific Drug Used When Initiating Illicit Drug Use among Past Year Initiates of Illicit Drugs Aged 12 or Older: 2007

5.2 Past Year Initiates for Specific Illicit Drugs among Persons Aged 12 or Older: 2007

5.3 Mean Age at First Use for Specific Illicit Drugs among Past Year Initiates Aged 12 to 49: 2007

5.4 Past Year Marijuana Initiates among Persons Aged 12 or Older and Mean Age at First Use of Marijuana among Past Year Marijuana Initiates Aged 12 to 49: 2002-2007

5.5 Past Year Ecstasy Initiates among Persons Aged 12 or Older and Mean Age at First Use of Ecstasy among Past Year Ecstasy Initiates Aged 12 to 49: 2002-2007

5.6 Past Year Methamphetamine Initiates among Persons Aged 12 or Older and Mean Age at First Use of Methamphetamine among Past Year Methamphetamine Initiates Aged 12 to 49: 2002-2007

5.7 Past Year Cigarette Initiates among Persons Aged 12 or Older, by Age at First Use: 2002-2007

5.8 Past Year Cigarette Initiation among Youths Aged 12 to 17 Who Had Never Smoked, by Gender: 2002-2007

6.1 Past Month Binge Drinking and Marijuana Use among Youths Aged 12 to 17, by Perceptions of Risk: 2007

6.2 Perceived Great Risk of Cigarette and Alcohol Use among Youths Aged 12 to 17: 2002-2007

6.3 Perceived Great Risk of Marijuana Use among Youths Aged 12 to 17: 2002-2007

6.4 Perceived Great Risk of Use of Selected Illicit Drugs among Youths Aged 12 to 17: 2002-2007

6.5 Perceived Availability of Selected Illicit Drugs among Youths Aged 12 to 17: 2002-2007

6.6 Approached in the Past Month by Someone Selling Drugs among Youths Aged 12 to 17: 2002-2007

6.7 Exposure to Substance Use Prevention Messages and Programs among Youths Aged 12 to 17: 2002-2007

7.1 Substance Dependence or Abuse in the Past Year among Persons Aged 12 or Older: 2002-2007

7.2 Dependence on or Abuse of Specific Illicit Drugs in the Past Year among Persons Aged 12 or Older: 2007

7.3 Alcohol Dependence or Abuse in the Past Year among Adults Aged 21 or Older, by Age at First Use of Alcohol: 2007

7.4 Substance Dependence or Abuse in the Past Year, by Age and Gender: 2007

7.5 Locations Where Past Year Substance Use Treatment Was Received among Persons Aged 12 or Older: 2007

7.6 Substances for Which Most Recent Treatment Was Received in the Past Year among Persons Aged 12 or Older: 2007

7.7 Past Year Perceived Need for and Effort Made to Receive Specialty Treatment among Persons Aged 12 or Older Needing But Not Receiving Treatment for Illicit Drug or Alcohol Use: 2007

7.8 Reasons for Not Receiving Substance Use Treatment among Persons Aged 12 or Older Who Needed and Made an Effort to Get Treatment But Did Not Receive Treatment and Felt They Needed Treatment: 2004-2007 Combined

8.1 Serious Psychological Distress in the Past Year among Adults Aged 18 or Older, by Age: 2006-2007

8.2 Number of Types of Mental Health Services Received in the Past Year among Persons Aged 18 or Older with Past Year Serious Psychological Distress Who Received Mental Health Services in the Past Year: 2007

8.3 Past Year Mental Health Care among Adults Aged 18 or Older with Both Serious Psychological Distress and a Substance Use Disorder: 2007

8.4 Major Depressive Episode in the Past Year among Adults Aged 18 or Older, by Severe Impairment, Age, and Gender: 2007

8.5 Substance Dependence or Abuse among Adults Aged 18 or Older, by Major Depressive Episode in the Past Year: 2007

8.6 Past Year Mental Health Service Use among Adults Aged 18 or Older, by Type of Care: 2002-2007

8.7 Reasons for Not Receiving Mental Health Services in the Past Year among Adults Aged 18 or Older with an Unmet Need for Mental Health Care Who Did Not Receive Mental Health Services: 2007

8.8 Major Depressive Episode in the Past Year among Youths Aged 12 to 17, by Severe Impairment, Age, and Gender: 2007

8.9 Substance Use among Youths Aged 12 to 17, by Major Depressive Episode in the Past Year: 2007

8.10 Past Year Mental Health Service Use among Youths Aged 12 to 17, by Gender: 2007

8.11 Number of Outpatient Visits in the Past Year among Youths Aged 12 to 17 Who Received Outpatient Specialty Mental Health Services: 2007

8.12 Number of Nights Stayed in an Inpatient Specialty Mental Health Facility in the Past Year among Youths Aged 12 to 17 Who Received Inpatient Specialty Mental Health Services: 2007

9.1 Past Month Marijuana Use among Youths in NSDUH, MTF, and YRBS: 1971-2007

B.1 Required Effective Sample as a Function of the Proportion Estimated

List of Tables

9.1 Comparison of NSDUH and MTF Prevalence Estimates among Youths: 2002-2007

9.2 Comparison of NSDUH and MTF Prevalence Estimates among Young Adults: 2002-2007

B.1 Demographic and Geographic Domains Forced to Match Their Respective U.S. Census Bureau Population Estimates through the Weight Calibration Process, 2007

B.2 Summary of 2007 NSDUH Suppression Rules

B.3 Weighted Percentages and Sample Sizes for 2006 and 2007 NSDUHs, by Screening Result Code

B.4 Weighted Percentages and Sample Sizes for 2006 and 2007 NSDUHs, by Final Interview Code

B.5 Response Rates and Sample Sizes for 2006 and 2007 NSDUHs, by Demographic Characteristics

B.6 Nonmedical Use of Methamphetamine in Lifetime, Past Year, and Past Month, by Demographic Characteristics: Percentages Based on Different Estimation Methods, 2002-2007

B.7 Nonmedical Use of Stimulants in Lifetime, Past Year, and Past Month, by Demographic Characteristics: Percentages Based on Different Estimation Methods, 2002-2007

B.8 Nonmedical Use of Psychotherapeutics in Lifetime, Past Year, and Past Month, by Demographic Characteristics: Percentages Based on Different Estimation Methods, 2002-2007

B.9 Nonmedical Use of Sedatives and Stimulants in the Lifetime, Past Year, and Past Month among Persons Aged 12 or Older Based on Different Estimation Methods, by Demographic Characteristics: Percentages, 2006 and 2007

B.10 Nonmedical Use of Prescription-Type Psychotherapeutics and Use of Hallucinogens in the Lifetime, Past Year, and Past Month among Persons Aged 12 or Older Based on Different Estimation Methods, by Demographic Characteristics: Percentages, 2006 and 2007

B.11 Illicit Drug Use and Illicit Drug Use Other Than Marijuana in the Lifetime, Past Year, and Past Month among Persons Aged 12 or Older Based on Different Estimation Methods, by Demographic Characteristics: Percentages, 2006 and 2007

D.1 Use of Specific Substances in Lifetime, Past Year, and Past Month among 8th, 10th, and 12th Graders in NSDUH and MTF: Percentages, 2006 and 2007

D.2 Lifetime and Past Month Substance Use among Students in Grades 9 to 12 in YRBS and NSDUH: 2005 and 2007

F.1 Survey Sample Size for Respondents Aged 12 or Older, by Gender and Detailed Age Category: 2006 and 2007

F.2 Numbers (in Thousands) of Persons Aged 12 or Older, by Gender and Detailed Age Category: 2006 and 2007

F.3 Survey Sample Size for Respondents Aged 12 or Older, by Age Group and Demographic Characteristics: 2006 and 2007

F.4 Numbers (in Thousands) of Persons Aged 12 or Older, by Age Group and Demographic Characteristics: 2006 and 2007

F.5 Survey Sample Size for Respondents Aged 12 or Older, by Age Group and Geographic Characteristics: 2006 and 2007

F.6 Numbers (in Thousands) of Persons Aged 12 or Older, by Age Group and Geographic Characteristics: 2006 and 2007

G.1 Types of Illicit Drug Use in Lifetime among Persons Aged 12 or Older: Numbers in Thousands, 2002-2007

G.2 Types of Illicit Drug Use in Lifetime among Persons Aged 12 or Older: Percentages, 2002-2007

G.3 Types of Illicit Drug Use in the Past Year among Persons Aged 12 or Older: Numbers in Thousands, 2002-2007

G.4 Types of Illicit Drug Use in the Past Year among Persons Aged 12 or Older: Percentages, 2002-2007

G.5 Types of Illicit Drug Use in the Past Month among Persons Aged 12 or Older: Numbers in Thousands, 2002-2007

G.6 Types of Illicit Drug Use in the Past Month among Persons Aged 12 or Older: Percentages, 2002-2007

G.7 Types of Illicit Drug Use in the Past Month among Persons Aged 12 to 17: Percentages, 2002-2007

G.8 Types of Illicit Drug Use in the Past Month among Persons Aged 18 to 25: Percentages, 2002-2007

G.9 Types of Illicit Drug Use in the Past Month among Persons Aged 26 or Older: Percentages, 2002-2007

G.10 Illicit Drug Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2006 and 2007

G.11 Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2006 and 2007

G.12 Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2006 and 2007

G.13 Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2006 and 2007

G.14 Tobacco Product and Alcohol Use in the Past Month among Persons Aged 12 or Older, by Gender: Numbers in Thousands, 2002-2007

G.15 Tobacco Product and Alcohol Use in the Past Month among Persons Aged 12 or Older, by Gender: Percentages, 2002-2007

G.16 Tobacco Product and Alcohol Use in the Past Month among Persons Aged 12 to 17, by Gender: Percentages, 2002-2007

G.17 Tobacco Product and Alcohol Use in the Past Month among Persons Aged 18 to 25, by Gender: Percentages, 2002-2007

G.18 Tobacco Product and Alcohol Use in the Past Month among Persons Aged 26 or Older, by Gender: Percentages, 2002-2007

G.19 Alcohol Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 20, by Gender: Percentages, 2002-2007

G.20 Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in the Past Month, by Detailed Age Category: Percentages, 2006 and 2007

G.21 Alcohol Use, Binge Alcohol Use, and Heavy Alcohol Use in the Past Month among Persons Aged 12 to 20, by Demographic Characteristics: Percentages, 2006 and 2007

G.22 Cigarette Use in Lifetime, Past Year, and Past Month, by Detailed Age Category: Percentages, 2006 and 2007

G.23 Cigarette Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2006 and 2007

G.24 Cigarette Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2006 and 2007

G.25 Perceived Risk and Availability of Substances among Persons Aged 12 to 17: Percentages, 2002-2007

G.26 Past Year Initiation of Substance Use among Persons Aged 12 or Older: Numbers in Thousands, 2002-2007

G.27 Substance Dependence or Abuse for Specific Substances in the Past Year among Persons Aged 12 or Older: Numbers in Thousands, 2002-2007

G.28 Substance Dependence or Abuse for Specific Substances in the Past Year among Persons Aged 12 or Older: Percentages, 2002-2007

G.29 Substance Dependence or Abuse in the Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2006 and 2007

G.30 Received Substance Use Treatment at Any Treatment Location or at a Specialty Facility in the Past Year among Persons Aged 12 or Older: Numbers in Thousands, 2002-2007

G.31 Received Substance Use Treatment at Any Treatment Location or at a Specialty Facility in the Past Year among Persons Aged 12 or Older: Percentages, 2002-2007

G.32 Needed and Received Treatment for a Substance Use Problem in the Past Year among Persons Aged 12 or Older: Numbers in Thousands, 2002-2007

G.33 Needed and Received Treatment for a Substance Use Problem in the Past Year among Persons Aged 12 or Older: Percentages, 2002-2007

G.34 Needed and Received Treatment for an Illicit Drug or Alcohol Problem in the Past Year among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2006 and 2007

G.35 Perceived Need for Illicit Drug or Alcohol Treatment and Whether Made an Effort to Get Treatment in the Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Illicit Drug or Alcohol Problem, by Demographic Characteristics: Numbers in Thousands, 2006 and 2007

G.36 Perceived Need for Illicit Drug or Alcohol Treatment and Whether Made an Effort to Get Treatment in the Past Year among Persons Aged 12 or Older Classified as Needing But Not Receiving Treatment for an Illicit Drug or Alcohol Problem, by Demographic Characteristics: Percentages, 2006 and 2007

G.37 Serious Psychological Distress in the Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2004-2007

G.38 Received Mental Health Treatment/Counseling in the Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2002-2007

G.39 Had at Least One Major Depressive Episode (MDE) in the Past Year among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2004-2007

G.40 Had at Least One Major Depressive Episode (MDE) in the Past Year among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2004-2007

G.41 Source of Mental Health Service in the Past Year among Persons Aged 12 to 17: Percentages, 2002-2007

Highlights

This report presents the first information from the 2007 National Survey on Drug Use and Health (NSDUH), an annual survey sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA). The survey is the primary source of information on the use of illicit drugs, alcohol, and tobacco in the civilian, noninstitutionalized population of the United States aged 12 years old or older. The survey interviews approximately 67,500 persons each year. Unless otherwise noted, all comparisons in this report described using terms such as "increased," "decreased," or "more than" are statistically significant at the .05 level.

Illicit Drug Use

Alcohol Use

Tobacco Use

Initiation of Substance Use (Incidence, or First-Time Use) within the Past 12 Months

Youth Prevention-Related Measures

Substance Dependence, Abuse, and Treatment

Mental Health

1. Introduction

This report presents the first information from the 2007 National Survey on Drug Use and Health (NSDUH), an annual survey of the civilian, noninstitutionalized population of the United States aged 12 years old or older. This initial report on the 2007 data presents national estimates of rates of use, numbers of users, and other measures related to illicit drugs, alcohol, and tobacco products. Measures related to mental health problems also are presented, including data on depression and on the co-occurrence of substance use and mental health problems. Estimates from NSDUH for States and areas within States will be presented in separate reports.

A major focus of this report is a comparison of substance use prevalence estimates between 2006 and 2007. Trends since 2002 also are discussed for some measures. Because of improvements to the survey in 2002, the 2002 data constitute a new baseline for tracking trends in substance use and other measures. Therefore, estimates from the 2002 through 2007 NSDUHs should not be compared with estimates from the 2001 and earlier surveys in the series to assess changes in substance use and mental health problems over time.

1.1. Summary of NSDUH

NSDUH is the primary source of statistical information on the use of illegal drugs by the U.S. population. Conducted by the Federal Government since 1971, the survey collects data by administering questionnaires to a representative sample of the population through face-to-face interviews at the respondent's place of residence. The survey is sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services, and is planned and managed by SAMHSA's Office of Applied Studies (OAS). Data collection and analysis are conducted under contract with RTI International, Research Triangle Park, North Carolina.1 This section briefly describes the survey methodology; a more complete description is provided in Appendix A.

NSDUH collects information from residents of households and noninstitutional group quarters (e.g., shelters, rooming houses, dormitories) and from civilians living on military bases. The survey excludes homeless persons who do not use shelters, military personnel on active duty, and residents of institutional group quarters, such as jails and hospitals. Appendix D describes surveys that cover populations outside the NSDUH target population.

Since 1999, the NSDUH interview has been carried out using computer-assisted interviewing (CAI). Most of the questions are administered with audio computer-assisted self-interviewing (ACASI). ACASI is designed to provide the respondent with a highly private and confidential means of responding to questions to increase the level of honest reporting of illicit drug use and other sensitive behaviors. Less sensitive items are administered by interviewers using computer-assisted personal interviewing (CAPI).

The 2007 NSDUH employed a State-based design with an independent, multistage area probability sample within each State and the District of Columbia. The eight States with the largest population (which together account for 48 percent of the total U.S. population aged 12 or older) were designated as large sample States (California, Florida, Illinois, Michigan, New York, Ohio, Pennsylvania, and Texas). For these States, the design provided a sample sufficient to support direct State estimates. For the remaining 42 States and the District of Columbia, smaller, but adequate, samples support State estimates using small area estimation (SAE) techniques. The design oversampled youths and young adults, so that each State's sample was approximately equally distributed among three age groups: 12 to 17 years, 18 to 25 years, and 26 years or older.

Nationally, 141,487 addresses were screened for the 2007 survey, and 67,870 completed interviews were obtained. The survey was conducted from January through December 2007. Weighted response rates for household screening and for interviewing were 89.5 and 73.9 percent, respectively. See Appendix B for more information on NSDUH response rates.

1.2. Trend Measurement

Although the design of the 2002 through 2007 NSDUHs is similar to the design of the 1999 through 2001 surveys, there are important methodological differences that affect the comparability of the 2002-2007 estimates with estimates from prior surveys. The most important change was the incentive payment started in 2002 and continuing in subsequent surveys. Each NSDUH respondent completing the interview is given $30. The name of the survey was also changed in 2002, from the National Household Survey on Drug Abuse (NHSDA) to the current name. In addition, improved data collection quality control procedures were introduced in the survey starting in 2001, and updated population data from the 2000 decennial census were incorporated into NSDUH sample weighting procedures starting with the 2002 estimates. Analyses of the effects of these factors on NSDUH estimates have shown that 2002 and later data should not be compared with 2001 and earlier data from the survey series to assess changes over time. Appendix C of the 2004 NSDUH report on national findings discusses this issue in more detail (see OAS, 2005b).

1.3. Change in Estimates for Psychotherapeutic Drugs and Stimulants

This report includes revised estimates of nonmedical use of prescription psychotherapeutic drugs and prescription stimulants that take into account data on methamphetamine use based on information obtained from survey items added to NSDUH in 2005, 2006, and 2007. The 2006 NSDUH national findings report incorporated revised estimates for methamphetamine use based on these new items (OAS, 2007b), and this report extends the revisions to use of stimulants and any prescription psychotherapeutics. In a methodological study, these measures were found to be noticeably higher when the data from the new methamphetamine use items were taken into account. Estimates for use of illicit drugs overall and use of illicit drugs other than marijuana, however, were affected only minimally by these methamphetamine use items and were not revised. See Section B.4.6 in Appendix B for more information on the results of this study.

The 2006 estimates for nonmedical use of stimulants and prescription psychotherapeutics in this report have been revised based on the additional questions on methamphetamine use, and statistical adjustments have been applied to the estimates from 2002 to 2005. These modifications control for the potentially confounding effects of the questionnaire changes and enable year-to-year comparisons to be made over the period from 2002 to 2007. Section B.4.6 in Appendix B provides a discussion of the revised measures and the procedures used to generate estimates based on them. Because of these changes, estimates for nonmedical use of stimulants and psychotherapeutic drugs in this report are not comparable to corresponding estimates in previous NSDUH reports. Methamphetamine use estimates in this report also are not comparable with those in NSDUH reports for survey years prior to 2006.

1.4. Format of Report and Explanation of Tables

This report has separate chapters that discuss the national findings on seven topics: use of illicit drugs; use of alcohol; use of tobacco products; initiation of substance use; prevention-related issues; substance dependence, abuse, and treatment; and mental health problems and treatment. A final chapter summarizes the results and discusses key findings in relation to other research and survey results. Technical appendices describe the survey (Appendix A), provide technical details on the statistical methods and measurement (Appendix B), offer key NSDUH definitions (Appendix C), discuss other sources of related data (Appendix D), list the references cited in the report (as well as other relevant references) (Appendix E), and present selected tabulations of estimates (Appendices F and G).

Tables, text, and figures present prevalence measures for the population in terms of both the number of persons and the percentage of the population. Substance use tables show prevalence estimates by lifetime (i.e., ever used), past year, and past month use. Analyses focus primarily on past month use, which also is referred to as "current use." Tables and figures in which estimates are presented by year have footnotes indicating whether the 2007 estimates are significantly different from 2006 or earlier estimates.

Statistical tests have been conducted for all statements appearing in the text of the report that compare estimates between years or subgroups of the population. Unless explicitly stated that a difference is not statistically significant, all statements that describe differences are significant at the .05 level. Statistically significant differences are described using terms such as "higher," "lower," "increased," and "decreased." Statements that use terms such as "similar," "no difference," "same," or "remained steady" to describe the relationship between estimates denote that a difference is not statistically significant. In addition, a set of estimates for survey years or population subgroups may be presented without a statement of comparison, in which case a statistically significant difference between these estimates is not implied and testing was not conducted.

All estimates presented in the report have met the criteria for statistical reliability (see Section B.2.2 of Appendix B). Estimates that do not meet these criteria are suppressed and do not appear in tables, figures, or text. Also, subgroups with suppressed estimates are not included in statistical tests of comparisons. For example, a statement that "whites had the highest prevalence" means that the rate among whites was higher than the rate among all nonsuppressed racial/ethnic subgroups, but not necessarily higher than the rate among a subgroup for which the estimate was suppressed.

Data are presented for racial/ethnic groups based on current guidelines for collecting and reporting race and ethnicity data (Office of Management and Budget [OMB], 1997). Because respondents were allowed to choose more than one racial group, a "two or more races" category is presented that includes persons who reported more than one category among the basic groups listed in the survey question (white, black or African American, American Indian or Alaska Native, Native Hawaiian, Other Pacific Islander, Asian, Other). Respondents choosing both Native Hawaiian and Other Pacific Islander but no other categories mentioned above are classified in the combined "Native Hawaiian or Other Pacific Islander" category instead of the "two or more race" category. It should be noted that, except for the "Hispanic or Latino" group, the racial/ethnic groups discussed in this report include only non-Hispanics. The category "Hispanic or Latino" includes Hispanics of any race.

Data also are presented for four U.S. geographic regions and nine geographic divisions within these regions. These regions and divisions, defined by the U.S. Census Bureau, consist of the following groups of States:

Northeast Region - New England Division: Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, Vermont; Middle Atlantic Division: New Jersey, New York, Pennsylvania.

Midwest Region - East North Central Division: Illinois, Indiana, Michigan, Ohio, Wisconsin; West North Central Division: Iowa, Kansas, Minnesota, Missouri, Nebraska, North Dakota, South Dakota.

South Region - South Atlantic Division: Delaware, District of Columbia, Florida, Georgia, Maryland, North Carolina, South Carolina, Virginia, West Virginia; East South Central Division: Alabama, Kentucky, Mississippi, Tennessee; West South Central Division: Arkansas, Louisiana, Oklahoma, Texas.

West Region - Mountain Division: Arizona, Colorado, Idaho, Montana, Nevada, New Mexico, Utah, Wyoming; Pacific Division: Alaska, California, Hawaii, Oregon, Washington.

Geographic comparisons also are made based on county type, a variable that reflects different levels of urbanicity and metropolitan area inclusion of counties, based on metropolitan area definitions issued by the OMB in June 2003 (OMB, 2003). For this purpose, counties are grouped based on the 2003 rural-urban continuum codes. These codes were originally developed by the U.S. Department of Agriculture (Butler & Beale, 1994). Each county is either inside or outside a metropolitan statistical area (MSA), as defined by the OMB.

Large metropolitan areas have a population of 1 million or more. Small metropolitan areas have a population of fewer than 1 million. Small metropolitan areas are further classified based on whether they have a population of 250,000 or more. Nonmetropolitan areas are areas outside MSAs. Counties in nonmetropolitan areas are further classified based on the number of people in the county who live in an urbanized area, as defined by the Census Bureau at the subcounty level. "Urbanized" counties have a population of 20,000 or more in urbanized areas, "less urbanized" counties have at least 2,500 but fewer than 20,000 population in urbanized areas, and "completely rural" counties have fewer than 2,500 population in urbanized areas.

1.5. Other NSDUH Reports and Data

Other reports focusing on specific topics of interest will be produced using the 2007 NSDUH data and made available on SAMHSA's website. A report on State-level estimates for 2006-2007 will be available in early 2009.

A comprehensive set of tables, referred to as "detailed tables," is available through the Internet at http://oas.samhsa.gov. The tables are organized into sections based primarily on the topic, and most tables are provided in several parts, showing population estimates (e.g., numbers of drug users), rates (e.g., percentages of population using drugs), and standard errors of all nonsuppressed estimates. A small subset of these detailed tables has been selected for inclusion in Appendices F and G of this report. The appendix tables can be mapped back to the detailed tables by using the table number in parentheses in the upper left corner of each table (e.g., Table G.1 in Appendix G is Table 8.1A in the detailed tables). Additional methodological information on NSDUH, including the questionnaire, is available electronically at the same web address.

Brief descriptive reports and in-depth analytic reports focusing on specific issues or population groups also are produced by OAS. A complete listing of previously published reports from NSDUH and other data sources is available from OAS. Most of these reports also are available through the Internet (http://oas.samhsa.gov). In addition, OAS makes public use data files available to researchers through the Substance Abuse and Mental Health Data Archive (SAMHDA, 2008) at http://www.icpsr.umich.edu/SAMHDA/index.html. Currently, files are available from the 1979 to 2006 surveys.2 The 2007 NSDUH public use file will be available by the end of 2008.

2. Illicit Drug Use

The National Survey on Drug Use and Health (NSDUH) obtains information on nine different categories of illicit drug use: use of marijuana, cocaine, heroin, hallucinogens, and inhalants; and the nonmedical use of prescription-type pain relievers, tranquilizers, stimulants, and sedatives. In these categories, hashish is included with marijuana, and crack is considered a form of cocaine. Several drugs are grouped under the hallucinogens category, including LSD, PCP, peyote, mescaline, psilocybin mushrooms, and "Ecstasy" (MDMA). Inhalants include a variety of substances, such as nitrous oxide, amyl nitrite, cleaning fluids, gasoline, spray paint, other aerosol sprays, and glue. The four categories of prescription-type drugs (pain relievers, tranquilizers, stimulants, and sedatives) cover numerous medications available by prescription and drugs within these groupings that may be manufactured illegally, such as methamphetamine, which is included under stimulants. Respondents are asked to report only "nonmedical" use of these drugs, defined as use without a prescription of the individual's own or simply for the experience or feeling the drugs caused. Use of over-the-counter drugs and legitimate use of prescription drugs are not included. NSDUH reports combine the four prescription-type drug groups into a category referred to as "psychotherapeutics."

Estimates of "illicit drug use" reported from NSDUH reflect the use of any of the nine drug categories listed above. Use of alcohol and tobacco products, while illegal for youths, is not included in these estimates, but is discussed in Chapters 3 and 4.

This chapter includes revised estimates of the nonmedical use of prescription psychotherapeutic drugs and prescription stimulants that take into account data on methamphetamine use based on information obtained from survey items added to NSDUH in 2005, 2006, and 2007. The 2006 NSDUH national findings report incorporated revised estimates for methamphetamine use based on these additional items (Office of Applied Studies [OAS], 2007b), and this report extends the revisions to use of stimulants and any prescription psychotherapeutics. In a methodological study, these measures were found to be noticeably higher when the data from the additional methamphetamine use items were taken into account. Estimates for use of illicit drugs overall and use of illicit drugs other than marijuana, however, were affected only minimally by these methamphetamine use items and were not revised. See Section B.4.6 in Appendix B for more information on the results of this study.

The 2006 estimates for nonmedical use of stimulants and prescription psychotherapeutics in this report have been revised based on the additional questions on methamphetamine use, and statistical adjustments have been applied to the estimates from 2002 to 2005. These modifications control for the potentially confounding effects of the questionnaire changes and enable year-to-year comparisons to be made over the period from 2002 to 2007. Section B.4.6 in Appendix B provides a discussion of the revised measures and the procedures used to generate estimates based on them. Because of these changes, estimates for the nonmedical use of stimulants and psychotherapeutic drugs in this report are not comparable with corresponding estimates in previous NSDUH reports. Methamphetamine use estimates in this report also are not comparable with those in NSDUH reports for survey years prior to 2006.

Below are two bar graphs. Click here for the text describing these graphs.

Figure 2.1 Past Month Illicit Drug Use among Persons Aged 12 or Older: 2007

Figure 2.1

1 Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically.

Below is a line graph. Click here for the text describing this graph.

Figure 2.2 Past Month Use of Selected Illicit Drugs among Persons Aged 12 or Older: 2002-2007

Figure 2.2

+ Difference between this estimate and the 2007 estimate is statistically significant at the .05 level.

Below is a line graph. Click here for the text describing this graph.

Figure 2.3 Past Month Nonmedical Use of Types of Psychotherapeutic Drugs among Persons Aged 12 or Older: 2002-2007

Figure 2.3

+ Difference between this estimate and the 2007 estimate is statistically significant at the .05 level.

Age

Below is a bar graph. Click here for the text describing this graph.

Figure 2.4 Past Month Illicit Drug Use among Persons Aged 12 or Older, by Age: 2007

Figure 2.4

Below is a line graph. Click here for the text describing this graph.

Figure 2.5 Past Month Use of Selected Illicit Drugs among Youths Aged 12 to 17: 2002-2007

Figure 2.5

+ Difference between this estimate and the 2007 estimate is statistically significant at the .05 level.

Youths Aged 12 to 17

Young Adults Aged 18 to 25

Below is a line graph. Click here for the text describing this graph.

Figure 2.6 Past Month Use of Selected Illicit Drugs among Young Adults Aged 18 to 25: 2002-2007

Figure 2.6

+ Difference between this estimate and the 2007 estimate is statistically significant at the .05 level.

Adults Aged 26 or Older

Below is a line graph. Click here for the text describing this graph.

Figure 2.7 Past Month Illicit Drug Use among Adults Aged 50 to 59: 2002-2007

Figure 2.7

+ Difference between this estimate and the 2007 estimate is statistically significant at the .05 level.

Gender